Repligen
RGEN
#2393
Rank
HK$61.04 B
Marketcap
HK$1,082
Share price
-6.12%
Change (1 day)
10.85%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of March 2026 : HK$6.15 Billion

According to Repligen 's latest financial reports the company has HK$6.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$5.97 B1.58%
2024-12-31HK$5.87 B0.2%
2023-12-31HK$5.86 B20.4%
2022-12-31HK$4.87 B3.51%
2021-12-31HK$4.70 B-15.33%
2020-12-31HK$5.56 B35.12%
2019-12-31HK$4.11 B171.13%
2018-12-31HK$1.51 B11.8%
2017-12-31HK$1.35 B23.48%
2016-12-31HK$1.09 B97.63%
2015-12-31HK$0.55 B22.7%
2014-12-31HK$0.45 B-5.12%
2013-12-31HK$0.47 B53.91%
2012-12-31HK$0.31 B
2011-03-31HK$0.38 B-6.46%
2010-03-31HK$0.41 B8.98%
2009-03-31HK$0.37 B-2.26%
2008-03-31HK$0.38 B119.12%
2007-03-31HK$0.17 B20.21%
2006-03-31HK$0.14 B9.62%
2005-03-31HK$0.13 B23.48%
2004-03-31HK$0.10 B-10.28%
2003-03-31HK$0.12 B-25.5%
2002-03-31HK$0.16 B-12.93%
2001-03-31HK$0.18 B-29.54%
2000-03-31HK$0.26 B935.59%
1999-03-31HK$25.58 M-29.76%
1998-03-31HK$36.42 M34.3%
1997-03-31HK$27.11 M-49.18%
1996-03-31HK$53.36 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$102.52 B 1,566.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$25.53 B 315.03%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$86.10 B 1,299.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$82.22 B 1,236.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.23 B-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$6.19 B 0.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$10.32 B 67.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$1.64 B-73.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$17.42 B 183.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$1.50 B-75.55%๐Ÿ‡บ๐Ÿ‡ธ USA